Logo image of NYT

NEW YORK TIMES CO-A (NYT) Stock Fundamental Analysis

USA - NYSE:NYT - US6501111073 - Common Stock

54.97 USD
+0.31 (+0.57%)
Last: 10/13/2025, 8:04:00 PM
54.97 USD
0 (0%)
After Hours: 10/13/2025, 8:04:00 PM
Fundamental Rating

7

Taking everything into account, NYT scores 7 out of 10 in our fundamental rating. NYT was compared to 95 industry peers in the Media industry. NYT has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. NYT has a correct valuation and a medium growth rate. These ratings would make NYT suitable for quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year NYT was profitable.
In the past year NYT had a positive cash flow from operations.
In the past 5 years NYT has always been profitable.
NYT had a positive operating cash flow in each of the past 5 years.
NYT Yearly Net Income VS EBIT VS OCF VS FCFNYT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1.2 Ratios

Looking at the Return On Assets, with a value of 11.42%, NYT belongs to the top of the industry, outperforming 94.74% of the companies in the same industry.
Looking at the Return On Equity, with a value of 16.55%, NYT belongs to the top of the industry, outperforming 86.32% of the companies in the same industry.
NYT's Return On Invested Capital of 14.36% is amongst the best of the industry. NYT outperforms 95.79% of its industry peers.
NYT had an Average Return On Invested Capital over the past 3 years of 11.43%. This is above the industry average of 8.50%.
The last Return On Invested Capital (14.36%) for NYT is above the 3 year average (11.43%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 11.42%
ROE 16.55%
ROIC 14.36%
ROA(3y)8.59%
ROA(5y)7.74%
ROE(3y)13.1%
ROE(5y)12.23%
ROIC(3y)11.43%
ROIC(5y)10.49%
NYT Yearly ROA, ROE, ROICNYT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

NYT has a better Profit Margin (11.92%) than 84.21% of its industry peers.
NYT's Profit Margin has improved in the last couple of years.
NYT has a better Operating Margin (15.50%) than 82.11% of its industry peers.
NYT's Operating Margin has improved in the last couple of years.
NYT's Gross Margin of 50.04% is in line compared to the rest of the industry. NYT outperforms 56.84% of its industry peers.
NYT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 15.5%
PM (TTM) 11.92%
GM 50.04%
OM growth 3Y3.09%
OM growth 5Y7.54%
PM growth 3Y2.34%
PM growth 5Y8.02%
GM growth 3Y-0.36%
GM growth 5Y-4.15%
NYT Yearly Profit, Operating, Gross MarginsNYT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

8

2. Health

2.1 Basic Checks

NYT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for NYT has been reduced compared to 1 year ago.
NYT has less shares outstanding than it did 5 years ago.
There is no outstanding debt for NYT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
NYT Yearly Shares OutstandingNYT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
NYT Yearly Total Debt VS Total AssetsNYT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 8.94 indicates that NYT is not in any danger for bankruptcy at the moment.
The Altman-Z score of NYT (8.94) is better than 92.63% of its industry peers.
There is no outstanding debt for NYT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.94
ROIC/WACC1.65
WACC8.69%
NYT Yearly LT Debt VS Equity VS FCFNYT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.48 indicates that NYT should not have too much problems paying its short term obligations.
The Current ratio of NYT (1.48) is better than 62.11% of its industry peers.
NYT has a Quick Ratio of 1.48. This is a normal value and indicates that NYT is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.48, NYT is in the better half of the industry, outperforming 63.16% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.48
Quick Ratio 1.48
NYT Yearly Current Assets VS Current LiabilitesNYT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 22.40% over the past year.
Measured over the past years, NYT shows a quite strong growth in Earnings Per Share. The EPS has been growing by 16.92% on average per year.
NYT shows a small growth in Revenue. In the last year, the Revenue has grown by 7.82%.
Measured over the past years, NYT shows a small growth in Revenue. The Revenue has been growing by 7.37% on average per year.
EPS 1Y (TTM)22.4%
EPS 3Y16.23%
EPS 5Y16.92%
EPS Q2Q%28.89%
Revenue 1Y (TTM)7.82%
Revenue growth 3Y7.62%
Revenue growth 5Y7.37%
Sales Q2Q%9.72%

3.2 Future

Based on estimates for the next years, NYT will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.13% on average per year.
Based on estimates for the next years, NYT will show a small growth in Revenue. The Revenue will grow by 6.49% on average per year.
EPS Next Y18.39%
EPS Next 2Y12.53%
EPS Next 3Y12.43%
EPS Next 5Y13.13%
Revenue Next Year7.96%
Revenue Next 2Y7.1%
Revenue Next 3Y6.62%
Revenue Next 5Y6.49%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
NYT Yearly Revenue VS EstimatesNYT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
NYT Yearly EPS VS EstimatesNYT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

4

4. Valuation

4.1 Price/Earnings Ratio

NYT is valuated rather expensively with a Price/Earnings ratio of 24.54.
Compared to the rest of the industry, the Price/Earnings ratio of NYT indicates a somewhat cheap valuation: NYT is cheaper than 65.26% of the companies listed in the same industry.
NYT is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.34, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 21.60 indicates a rather expensive valuation of NYT.
NYT's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.86. NYT is around the same levels.
Industry RankSector Rank
PE 24.54
Fwd PE 21.6
NYT Price Earnings VS Forward Price EarningsNYT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as NYT.
NYT's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 19.66
EV/EBITDA 16.1
NYT Per share dataNYT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of NYT may justify a higher PE ratio.
A more expensive valuation may be justified as NYT's earnings are expected to grow with 12.43% in the coming years.
PEG (NY)1.33
PEG (5Y)1.45
EPS Next 2Y12.53%
EPS Next 3Y12.43%

6

5. Dividend

5.1 Amount

NYT has a Yearly Dividend Yield of 1.30%. Purely for dividend investing, there may be better candidates out there.
NYT's Dividend Yield is a higher than the industry average which is at 4.36.
With a Dividend Yield of 1.30, NYT pays less dividend than the S&P500 average, which is at 2.44.
Industry RankSector Rank
Dividend Yield 1.3%

5.2 History

On average, the dividend of NYT grows each year by 21.48%, which is quite nice.
NYT has paid a dividend for at least 10 years, which is a reliable track record.
NYT has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)21.48%
Div Incr Years6
Div Non Decr Years11
NYT Yearly Dividends per shareNYT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

29.50% of the earnings are spent on dividend by NYT. This is a low number and sustainable payout ratio.
The dividend of NYT is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP29.5%
EPS Next 2Y12.53%
EPS Next 3Y12.43%
NYT Yearly Income VS Free CF VS DividendNYT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
NYT Dividend Payout.NYT Dividend Payout, showing the Payout Ratio.NYT Dividend Payout.PayoutRetained Earnings

NEW YORK TIMES CO-A

NYSE:NYT (10/13/2025, 8:04:00 PM)

After market: 54.97 0 (0%)

54.97

+0.31 (+0.57%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)10-29 2025-10-29/bmo
Inst Owners98.63%
Inst Owner Change-0.29%
Ins Owners0.61%
Ins Owner Change-0.15%
Market Cap8.95B
Analysts75
Price Target58.59 (6.59%)
Short Float %6.77%
Short Ratio5.84
Dividend
Industry RankSector Rank
Dividend Yield 1.3%
Yearly Dividend0.5
Dividend Growth(5Y)21.48%
DP29.5%
Div Incr Years6
Div Non Decr Years11
Ex-Date10-08 2025-10-08 (0.18)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.94%
Min EPS beat(2)15.73%
Max EPS beat(2)18.14%
EPS beat(4)4
Avg EPS beat(4)12.21%
Min EPS beat(4)6.49%
Max EPS beat(4)18.14%
EPS beat(8)8
Avg EPS beat(8)19.88%
EPS beat(12)12
Avg EPS beat(12)28.39%
EPS beat(16)16
Avg EPS beat(16)25.56%
Revenue beat(2)1
Avg Revenue beat(2)0.21%
Min Revenue beat(2)-0.82%
Max Revenue beat(2)1.24%
Revenue beat(4)1
Avg Revenue beat(4)-0.41%
Min Revenue beat(4)-1.09%
Max Revenue beat(4)1.24%
Revenue beat(8)2
Avg Revenue beat(8)-0.53%
Revenue beat(12)4
Avg Revenue beat(12)-0.43%
Revenue beat(16)6
Avg Revenue beat(16)-0.34%
PT rev (1m)0%
PT rev (3m)0.57%
EPS NQ rev (1m)0%
EPS NQ rev (3m)9.21%
EPS NY rev (1m)1.29%
EPS NY rev (3m)7.25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.76%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.18%
Valuation
Industry RankSector Rank
PE 24.54
Fwd PE 21.6
P/S 3.33
P/FCF 19.66
P/OCF 18.27
P/B 4.62
P/tB 6.98
EV/EBITDA 16.1
EPS(TTM)2.24
EY4.07%
EPS(NY)2.55
Fwd EY4.63%
FCF(TTM)2.8
FCFY5.09%
OCF(TTM)3.01
OCFY5.47%
SpS16.51
BVpS11.89
TBVpS7.88
PEG (NY)1.33
PEG (5Y)1.45
Profitability
Industry RankSector Rank
ROA 11.42%
ROE 16.55%
ROCE 18.71%
ROIC 14.36%
ROICexc 18.96%
ROICexgc 30.93%
OM 15.5%
PM (TTM) 11.92%
GM 50.04%
FCFM 16.93%
ROA(3y)8.59%
ROA(5y)7.74%
ROE(3y)13.1%
ROE(5y)12.23%
ROIC(3y)11.43%
ROIC(5y)10.49%
ROICexc(3y)14.65%
ROICexc(5y)14.2%
ROICexgc(3y)25.48%
ROICexgc(5y)21.57%
ROCE(3y)14.89%
ROCE(5y)13.67%
ROICexcg growth 3Y17%
ROICexcg growth 5Y17.39%
ROICexc growth 3Y3.36%
ROICexc growth 5Y8.52%
OM growth 3Y3.09%
OM growth 5Y7.54%
PM growth 3Y2.34%
PM growth 5Y8.02%
GM growth 3Y-0.36%
GM growth 5Y-4.15%
F-Score9
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 41.07%
Cap/Sales 1.29%
Interest Coverage 250
Cash Conversion 97.77%
Profit Quality 142.1%
Current Ratio 1.48
Quick Ratio 1.48
Altman-Z 8.94
F-Score9
WACC8.69%
ROIC/WACC1.65
Cap/Depr(3y)35.41%
Cap/Depr(5y)44.4%
Cap/Sales(3y)1.22%
Cap/Sales(5y)1.45%
Profit Quality(3y)113.54%
Profit Quality(5y)142.07%
High Growth Momentum
Growth
EPS 1Y (TTM)22.4%
EPS 3Y16.23%
EPS 5Y16.92%
EPS Q2Q%28.89%
EPS Next Y18.39%
EPS Next 2Y12.53%
EPS Next 3Y12.43%
EPS Next 5Y13.13%
Revenue 1Y (TTM)7.82%
Revenue growth 3Y7.62%
Revenue growth 5Y7.37%
Sales Q2Q%9.72%
Revenue Next Year7.96%
Revenue Next 2Y7.1%
Revenue Next 3Y6.62%
Revenue Next 5Y6.49%
EBIT growth 1Y22.62%
EBIT growth 3Y10.95%
EBIT growth 5Y15.46%
EBIT Next Year37.56%
EBIT Next 3Y18.17%
EBIT Next 5YN/A
FCF growth 1Y101.81%
FCF growth 3Y17.6%
FCF growth 5Y21.42%
OCF growth 1Y92.64%
OCF growth 3Y15.12%
OCF growth 5Y16.67%